Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Octreotide acetate (20mg) Injection
Therapeutic Category
Endocrinology, Gastroenterology
Dosage Form
Injection
Packaging Type
Vial
Packaging
20mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Octrate 20 Injection containing Octreotide Acetate is used for the management of hormonal and gastrointestinal disorders. It helps in controlling excessive hormone secretion and associated complications.
Octreotide works as a somatostatin analogue that suppresses the release of various hormones and gastrointestinal secretions, helping improve symptom control and disease management.
The injection is widely used in endocrinology, gastroenterology, and critical care settings for specialized therapeutic management, leading to consistent demand in hospital care.
With increasing need for advanced specialty care therapies and critical care management solutions, this product offers strong business potential for distributors and institutional suppliers. Its specialized hospital usage, steady clinical demand, and broad therapeutic relevance make it a reliable product for consistent sales and growth in the specialty care segment.
Some patients may experience abdominal pain, nausea, diarrhea, constipation, injection site discomfort, or headache. Rarely, gallstones, blood glucose disturbances, thyroid dysfunction, or liver enzyme changes may occur and require medical attention.
Octrate 20 Injection is indicated for the treatment of acromegaly, carcinoid tumors, vasoactive intestinal peptide-secreting tumors (VIPomas), and other hormone-secreting gastrointestinal disorders. It helps control hormonal imbalance, reduce flushing and diarrhea, and improve symptom management in chronic endocrine conditions.
This injection should be administered under strict medical supervision. Regular monitoring of blood glucose levels, thyroid function, gallbladder health, and hormone levels is recommended during long-term therapy. Use cautiously in diabetic patients.
Store in a refrigerator between 2°C to 8°C. Do not freeze. Protect from light and keep out of reach of children.
Composition : Omeprazole (20mg) Capsule
Composition : Domperidone (10mg) + Omeprazole (20mg) in Strip Packing of 15 Tablets
Composition : Pantoprazole (E.C.) I.P. 40mg (E.C.) + Domperidone (I.R.) I.P. 10mg + Domperidone (S.R.) I.P. 20mg Capsules
Composition : Pantoprazole (40mg) + Itopride (150mg)
Composition : Rabeprazole Sodium (E.C.) I.P. 20mg + Domperidone (S.R.) I.P. 20mg + Domperidone (I.R.) I.P. 10mg
Composition : Rabeprazole (20mg) + Itopride (150mg)
Composition : Lansoprazole (15mg) Tablet
Composition : Lansoprazole (30mg)
Composition : Levosulpiride (75mg) + Pantoprazole (40mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Octrate 20 Injection, containing Octreotide acetate 20mg, has strong demand in the super-specialty hospital segment, making it a high-value injectable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastroenterology, oncology, and endocrinology portfolios.
Medical distributors and agencies can benefit from the consistent hospital demand for somatostatin analog therapy used in acromegaly, carcinoid syndrome, VIPomas, and certain bleeding and endocrine-related conditions. Octrate 20 Injection helps strengthen a specialized critical care and super-specialty injectable portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Octrate 20 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high-value institutional demand, hospital-based prescriptions, reliable supply chain support, and strong margins when partnering for Octrate 20 Injection distribution.
Medical distributors, stockists, and wholesalers interested in Octrate 20 Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.